Tag: #Global Trends

India's healthcare investment landscape is entering a new phase as Maxivision Super Specialty Eye Hospitals, backed by private equity firm... Read more

GSK has reported encouraging Phase II clinical results for Jemperli (dostarlimab) in patients with locally advanced mismatch repair deficient (dMMR)... Read more

The understanding of obesity continues to evolve as medical experts increasingly recognize it as a chronic, relapsing disease rather than... Read more

The U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG) reported that its oversight activities generated an... Read more

China Medical System (CMS) has entered into a research collaboration and licensing agreement with Insilico Medicine to develop innovative therapies... Read more

GSK announced that Risvanzutibart (Ris-Rez), an antibody-drug conjugate (ADC) targeting B7-H3, achieved positive results in a Phase III clinical trial... Read more

Key Development The European Commission has approved AbbVie and Genmab's bispecific antibody TEPKINLY (epcoritamab) in combination with lenalidomide and rituximab... Read more

Key Development AstraZeneca and Ionis Pharmaceuticals announced that a late-stage clinical trial evaluating eplontersen for transthyretin amyloid cardiomyopathy (ATTR-CM) failed... Read more

Key Development China has taken another significant step in reshaping diabetes care by adding semaglutide, the second GLP-1 receptor agonist... Read more